<DOC>
	<DOCNO>NCT00152022</DOCNO>
	<brief_summary>The purpose study assess safety effectiveness SPD465 compare placebo ( capsule medication ) treatment ADHD . The study also look SPD465 affect participant sleep perceive quality life .</brief_summary>
	<brief_title>Efficacy Safety SPD465 Adults With Moderately Symptomatic ADHD .</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Amphetamine</mesh_term>
	<mesh_term>Dextroamphetamine</mesh_term>
	<mesh_term>Adderall</mesh_term>
	<criteria>Primary diagnosis ADHD Baseline ADHDRSIV score &gt; = 32 Nonpregnant female childbearing potential must comply contraceptive restriction . Significantly underweight morbidly obese Comorbid psychiatric diagnosis significant symptom Axis II disorder severe Axis I disorder History seizure , tic disorder , current diagnosis and/or family history Tourette 's Disorder Females pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>